RecruitingNCT06781242
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
Studying Sclerosing cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Principal Investigator
- Giovanni Vitale, MDIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment
- 300 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2025
Study locations (2)
- IRCCS - Azienda Ospedaliero-Universitaria di Bologna, Bologna, Bologna, Italy
- Ospedale Civile Sant'Agostino Estense Baggiovara, Modena, Modena, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06781242 on ClinicalTrials.govOther trials for Sclerosing cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07317193DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASEFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGPHASE1NCT06825559Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver DiseaseZydus Therapeutics Inc.
- ACTIVE NOT RECRUITINGNCT02545309Secondary Sclerosing Cholangitis in Critically Ill PatientsMedical University of Graz
- ACTIVE NOT RECRUITINGNANCT02601417The Necessity of Bile Cultures in Patients With Acute CholangitisSeoul National University Hospital